Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation

Deborah L. Regidor, Roger Detels, Elizabeth C. Breen, Daniel P. Widney, Lisa P. Jacobson, Frank Palella, Charles R. Rinaldo, Jay H. Bream, Otoniel Martínez-Maza

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: Chronic inflammation and B-cell hyperactivation are seen in HIV infection, contributing to an increased risk for the accrual of genetic errors that may result in B-cell lymphoma. The primary objective of this study was to determine the effect of highly active antiretroviral therapy (HAART) on serum levels of molecules that are associated with immune activation and/or inflammation, including several that are associated with B-cell activation, specifically IL-6, sCD30, sCD27, IgG, IgA, CXCL13 (B lymphocyte chemoattractant, BLC), a B-lymphocyte chemokine involved in B-cell trafficking, as well as C-reactive protein, an acute-phase protein. Design: We used a retrospective cohort study design, measuring serum levels of these markers at each of four 1-year intervals, 2 years before and 2 years after HAART initiation, in a subgroup of 290 HIV-infected men enrolled in the Multicenter AIDS Cohort Study (MACS). Methods: Serum levels of immune activation-associated molecules were measured by ELISA and multiplexed immunometric assays. Reference values were determined by the 5th to 95th percentiles from a sample of 109 HIV-uninfected MACS men. RESULTS: HAART use was associated with a reduction, but not normalization, of most biomarkers tested. Serum levels of IL-6 and C-reactive protein appeared to be unaffected by HAART. Conclusions: These results suggest a partial normalization of serum cytokine levels post HAART. However, a chronic state of B-cell hyperactivation continues 2-3 years after HAART initiation. These findings may explain, in part, the excess incidence of lymphoma still occurring in HIV-infected persons in the post-HAART era.

Original languageEnglish (US)
Pages (from-to)303-314
Number of pages12
JournalAIDS
Volume25
Issue number3
DOIs
StatePublished - Jan 28 2011

Keywords

  • AIDS
  • B lymphocytes
  • HIV
  • activation
  • antiretroviral therapy
  • highly active
  • non-Hodgkin's lymphoma

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation'. Together they form a unique fingerprint.

Cite this